Revenue grew 21% to £175.4m, with adjusted profit before tax up 23% and EPS up 24%. All divisions contributed to growth, especially Information Management and Technology, while Datashred was impacted by low paper prices. Strong cash generation supported acquisitions, dividends, and a share buyback…
Revenue and adjusted EBITDA declined year-over-year due to weak market conditions, but margins improved and the group maintained strong liquidity and leverage. Strategic actions, including cost reductions and production alignment, position the business for future recovery despite ongoing macroecono…
Organic sales grew 4.6% in H126, led by Consumer Care, with adjusted operating profit up 6.7% and free cash flow rising 36.8%. Transformation savings and disciplined capex supported margin expansion, while the FY26 outlook remains unchanged despite macro uncertainty.Original document: Croda Interna…
Record AUM of $253.6bn was achieved, driven by strong investment performance and $7.1bn net inflows, with core profit before tax doubling year-over-year and EPS rising sharply. Diversified strategies and disciplined capital allocation supported robust financials, despite ongoing market and geopolit…
Revenue rose 15.2% to £559.4m and operating profit surged 57.6% to £5.2m, driven by new contracts and strong demand in logistics and food sectors. Share buybacks reduced shares by 30%, and the group expects FY 2026 results at the top end of market expectations.Original document: Staffline Group plc…
Core organic revenue grew 9.6% in H1 2026, led by strong Aerospace & Defence and IGT demand, while Automotive remained weak. Margins improved, EPS rose 18.3%, and the outlook for FY26 is unchanged, with continued focus on margin expansion and strategic site exits.Original document: Bodycote plc [BO…
Q2 2026 saw strong earnings growth, with statutory RoTE at 16.1% and profit before tax up 32% YoY. Income and NII guidance for FY26 were upgraded, capital distributions rose 61% YoY, and all major segments delivered double-digit RoTE.Original document: Barclays PLC [BARC] Slides Release — Jul. 28 2…
Vytis Reno Loans 2025-1 DAC (the Issuer) hereby informs that its audited financial statements for the financial year 2025, which under the securitisation transaction documents were required to be published by 30 June 2026, have not yet been finalised. The issuer is not subject to the statutory obli…
Q2 2026 RoTE reached 16.1% with income up 16% YoY to £8.3bn, and cost:income ratio improved to 54%. Capital distributions for H1 totaled £2.3bn, CET1 ratio stood at 14.3%, and all major business segments delivered strong returns. Guidance for FY26 income and NII was upgraded.Original document: Barc…
Strong H1 2026 results featured 4.8% underlying sales growth, led by volume and Power Brands, with emerging markets driving momentum. Underlying operating margin improved to 20.3%, and the Foods-McCormick combination is progressing. Full-year outlook upgraded, with continued focus on productivity…
European equity markets were set to open lower on Tuesday as investor sentiment weakened amid a global selloff in semiconductor stocks, fueled by mounting concerns over circular artificial intelligence financing arrangements and intensifying competition from China.The declines came even as oil pric…
Revenue surged 53% year-over-year to £37.6m in H1 2026, with adjusted profit before tax up 10% to £3.0m. A strengthened sales pipeline and recent acquisition support a positive outlook, with full-year revenue expected to slightly exceed market expectations.Original document: Journeo plc [JNEO] Earn…
Profit and sales growth exceeded expectations in H1 2026, led by Consumer Care and innovation-driven demand. Transformation initiatives delivered cost savings and margin improvements, with the FY26 outlook and FY28 financial targets reaffirmed.Original document: Croda International Plc [CRDA] Slide…
Revenue grew 49% YoY with strong margin expansion and robust AI-led services now at 86% of revenue. Encora integration delivered rapid synergies, boosting EBIT to 16% and order intake to $691M. FY27 guidance remains strong, with every vertical and geography set for growth.Based on Coforge Limited…
Strong ARR and CARR growth, improved revenue retention, and robust US market momentum drove results ahead of expectations. Increased investment supported long-term growth, with high revenue visibility into FY27 and a debt-free balance sheet.Original document: PCI-PAL PLC [PCIP] Earnings Release — J…
Revenue grew 18% year-over-year to £11.6 million in H1 2026, with all regions contributing to growth and significant gains in the Instrumentation and Clinical segments. Cash declined to £8.9 million due to the SCD acquisition, while restructuring aims to deliver £4 million in annualized savings.Ori…
H1 2026 trading met expectations, supported by new and back catalogue releases, with strong summer sales. Major H2 launches are expected to drive a H2-weighted FY26, with full year results anticipated in line with market consensus of £175.3m revenue and £50.7m adjusted EBITDA.Original document: Eve…
Strategic exit from VadoTech will lower FY26 revenue by £4m, with FY25 comparatives restated. Despite challenging trading conditions and delayed order conversion, adjusted operating margin is expected to remain at 20%, supported by a strong balance sheet.Original document: AB Dynamics plc [ABDP] Ea…
RNS Number : 0579O Inchcape PLC 28 July 2026 Inchcape plcCurrent £175m share buyback programme increased to £250mInchcape plc, the leading global automotive distributor, announces it has entered into an agreement with UBS AG London Branch ("UBS") with the effect of increasing its current share…
RNS Number : 0582O DSW Capital PLC 28 July 2026 28 July 2026DSW CAPITAL PLC("DSW Capital", "DSW" or the "Group")(AIM: DSW)Vesting of Share Option AwardDSW Capital, a profitable, mid-market, challenger professional services platform and owner of the Dow Schofield Watts and the DR Solicitors bran…
